GPC Biotech AG (ADR) (NASDAQOTH:GPCBY.DL)

CAPS Rating: No stars

The Company is publicly traded biopharmaceutical company focused on discovering, developing and commercializing new anticancer drugs.

Featured Broker Partners


Advertisement